Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
447
Cercador de publicacions

  • Fraile L.; Sopena A.; Chávez C.E.; Font-Font M.; Esquerda A.

    Autoantibodies to intrinsic factor can jeopardize pernicious anemia diagnosis: a case report

    ejournal International Federation of Clinical Chemistry and Laboratory Medicine 34 181-187. .

  • Valladares-Ayerbes M; Garcia-Alfonso P; Muñoz Luengo J; Pimentel Caceres PP; Castillo Trujillo OA; Vidal-Tocino R; Llanos M; Llorente Ayala B; Limon Miron ML; Salud A; Cirera Nogueras L; Garcia-Carbonero R; Safont MJ; Falco Ferrer E; Aparicio J; Vicente Conesa MA; Guillén-Ponce C; Garcia-Teijido P; Medina Magan MB; Busquier I; Salgado M; Lloansí Vila A

    Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.

    Cancers 14 -. .

    [doi:10.3390/cancers14246075]

  • Luis Recuero Díaz J; Almánzar SF; Munoz CG; Sierra JL; Porras ML; Medina DM; Vicuña MN; Moreno LS; Cantalejo MG; Porcel JM

    Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion.

    CIRUGIA ESPANOLA 100 673-683. .

    [doi:10.1016/j.cireng.2022.06.009]

  • Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Porcel, JM

    Nonmalignant Pleural Effusions.

    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE 43 570-582. .

    [doi:10.1055/s-0042-1748186]

  • Porcel, Jose Manuel

    Pleural mesothelioma.

    MEDICINA CLINICA 159 240-247. .

    [doi:10.1016/j.medcli.2022.03.007]

  • Kudo, M; Montal, R; Finn, RS; Castet, F; Ueshima, K; Nishida, N; Haber, PK; Hu, YY; Chiba, Y; Schwartz, M; Meyer, T; Lencioni, R; Llovet, JM

    Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies.

    CLINICAL CANCER RESEARCH 28 3443-3451. .

    [doi:10.1158/1078-0432.CCR-21-3135]

  • Hernández M; Nóvoa-Medina Y; Faner R; Palou E; Esquerda A; Castelblanco E; Wägner AM; Mauricio D

    Genetics: Is LADA just late onset type 1 diabetes?

    Frontiers in Endocrinology 13 916698-916698. .

    [doi:10.3389/fendo.2022.916698]

  • Mummadi, SR; Porcel, JM

    Securing the chest tube: in search of the elusive solution.

    EUROPEAN RESPIRATORY JOURNAL 60 -. .

    [doi:10.1183/13993003.00434-2022]

  • Parisi E; Marqués M; Pont M; Sorolla MA; Sorolla A

    Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer.

    Frontiers in oncology 12 912542-912542. .

    [doi:10.3389/fonc.2022.912542]

  • Jimenez-Fonseca, P; Gallardo, E; Arija, FA; Blanco, JM; Callejo, A; Lavin, DC; Rivas, MC; Mosquera, J; Rodrigo, A; Morillas, RS; Gonzalez, MV; Munoz, A; Carmona-Bayonas, A

    Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence

    EUROPEAN JOURNAL OF INTERNAL MEDICINE 100 33-45. .

    [doi:10.1016/j.ejim.2022.02.020]

  • Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]